|
|
Volumn 502, Issue 7471, 2013, Pages 284-285
|
|
Regulators weigh benefits of 'three-parent' fertilization.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
MITOCHONDRIAL DNA;
ANIMAL;
CELL NUCLEUS;
CLINICAL TRIAL (TOPIC);
EXTRACHROMOSOMAL INHERITANCE;
FEMALE;
FERTILIZATION IN VITRO;
FOOD AND DRUG ADMINISTRATION;
GENE THERAPY;
GENETICS;
HUMAN;
INFERTILITY, FEMALE;
LEGISLATION AND JURISPRUDENCE;
MALE;
MITOCHONDRIAL DISEASES;
NEWBORN;
NUCLEAR REPROGRAMMING;
OOCYTE DONATION;
PARENT;
PATIENT SAFETY;
PREGNANCY;
STANDARDS;
UNITED STATES;
ANIMALS;
CELL NUCLEUS;
CELLULAR REPROGRAMMING;
CLINICAL TRIALS AS TOPIC;
DNA, MITOCHONDRIAL;
EXTRACHROMOSOMAL INHERITANCE;
FEMALE;
FERTILIZATION IN VITRO;
GENETIC THERAPY;
HUMANS;
INFANT, NEWBORN;
INFERTILITY, FEMALE;
MALE;
MITOCHONDRIAL DISEASES;
OOCYTE DONATION;
PARENTS;
PATIENT SAFETY;
PREGNANCY;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 84891514204
PISSN: None
EISSN: 14764687
Source Type: Journal
DOI: 10.1038/502284a Document Type: Note |
|
Times cited : (13)
|
|
References (0)
|
